Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

By S. Brown, M. Greene, Sharon K. Gershon, E. Edwards, M. Braun. Arthritis & Rheumatism, 2002

684 citations recorded by the source corpus.

Subfields: Hematology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/643f3a96781bed4a3b44c91fbd2c246e290e4204

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Melvin

Citations in the corpus

• Effects of estrogen with and without progestin on urinary incontinence (2005, background): “This is supported by observations that the proinflammatory cytokine tumor necrosis factor antagonists used to treat rheumatoid arthritis and Crohn disease are related to increased risk for lymphoma (21).”